BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 11145572)

  • 1. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
    Devi GR; Graham DL; Oh Y; Rosenfeld RG
    Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
    Ricort JM; Binoux M
    J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
    Lalou C; Lassarre C; Binoux M
    Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
    J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
    Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
    Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).
    Fottner C; Engelhardt D; Weber MM
    Horm Metab Res; 1999; 31(2-3):203-8. PubMed ID: 10226803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action.
    Mohseni-Zadeh S; Binoux M
    Endocrinology; 1997 Dec; 138(12):5645-8. PubMed ID: 9389554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
    Yee D; Jackson JG; Kozelsky TW; Figueroa JA
    Cell Growth Differ; 1994 Jan; 5(1):73-7. PubMed ID: 7510125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid.
    Shemer J; Yaron A; Werner H; Shao ZM; Sheikh MS; Fontana JA; LeRoith D; Roberts CT
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1246-50. PubMed ID: 7521344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.
    Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B
    Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and insulin-like growth factors (IGFs) stimulate production of IGF-binding proteins by ovarian granulosa cells.
    Grimes RW; Hammond JM
    Endocrinology; 1992 Aug; 131(2):553-8. PubMed ID: 1379161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
    Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
    Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.